Literature DB >> 16877362

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Marcella Marcellini1, Naomi De Luca, Teresa Riccioni, Alessandro Ciucci, Angela Orecchia, Pedro Miguel Lacal, Federica Ruffini, Maurizio Pesce, Francesca Cianfarani, Giovanna Zambruno, Augusto Orlandi, Cristina Maria Failla.   

Abstract

Placenta growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in adult pathological angiogenesis. To further investigate PlGF functions in tumor growth and metastasis formation, we used transgenic mice overexpressing PlGF in the skin under the control of the keratin 14 promoter. These animals showed a hypervascularized phenotype of the skin and increased levels of circulating PlGF with respect to their wild-type littermates. Transgenic mice and controls were inoculated intradermally with B16-BL6 melanoma cells. The tumor growth rate was fivefold increased in transgenic animals compared to wild-type mice, in the presence of a similar percentage of tumor necrotic tissue. Tumor vessel area was increased in transgenic mice as compared to controls. Augmented mobilization of endothelial and hematopoietic stem cells from the bone marrow was observed in transgenic animals, possibly contributing to tumor vascularization. The number and size of pulmonary metastases were significantly higher in transgenic mice compared to wild-type littermates. Finally, PlGF promoted tumor cell invasion of the extracellular matrix and increased the activity of selected matrix metalloproteinases. These findings indicate that PlGF, in addition to enhancing tumor angiogenesis and favoring tumor growth, may directly influence melanoma dissemination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877362      PMCID: PMC1698793          DOI: 10.2353/ajpath.2006.051041

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.

Authors:  Xin Hong; Feng Jiang; Steven N Kalkanis; Zheng Gang Zhang; Xue-Peng Zhang; Ana C DeCarvalho; Mark Katakowski; Kevin Bobbitt; Tom Mikkelsen; Michael Chopp
Journal:  Cancer Lett       Date:  2005-06-20       Impact factor: 8.679

Review 3.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

4.  Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.

Authors:  U Graeven; W Fiedler; S Karpinski; S Ergün; N Kilic; U Rodeck; W Schmiegel; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1999-11       Impact factor: 4.553

5.  Placenta growth factor is induced in human keratinocytes during wound healing.

Authors:  C M Failla; T Odorisio; F Cianfarani; C Schietroma; P Puddu; G Zambruno
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

6.  Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

Authors:  P M Lacal; C M Failla; E Pagani; T Odorisio; C Schietroma; S Falcinelli; G Zambruno; S D'Atri
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

Review 7.  VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.

Authors:  Janice A Nagy; Ann M Dvorak; Harold F Dvorak
Journal:  Trends Cardiovasc Med       Date:  2003-07       Impact factor: 6.677

Review 8.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

9.  Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.

Authors:  Radia Tamarat; Jean-Sébastien Silvestre; Sophie Le Ricousse-Roussanne; Véronique Barateau; Laurence Lecomte-Raclet; Michel Clergue; Micheline Duriez; Gérard Tobelem; Bernard I Lévy
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Authors:  Monica Autiero; Johannes Waltenberger; Didier Communi; Andrea Kranz; Lieve Moons; Diether Lambrechts; Jens Kroll; Stephane Plaisance; Maria De Mol; Françoise Bono; Stefanie Kliche; Guido Fellbrich; Kurt Ballmer-Hofer; Domenico Maglione; Ulrike Mayr-Beyrle; Mieke Dewerchin; Saskia Dombrowski; Danica Stanimirovic; Paul Van Hummelen; Christoph Dehio; Daniel J Hicklin; Graziella Persico; Jean-Marc Herbert; David Communi; Masabumi Shibuya; Désiré Collen; Edward M Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  27 in total

1.  PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.

Authors:  Joao Incio; Josh Tam; Nuh N Rahbari; Priya Suboj; Dan T McManus; Shan M Chin; Trupti D Vardam; Ana Batista; Suboj Babykutty; Keehoon Jung; Anna Khachatryan; Tai Hato; Jennifer A Ligibel; Ian E Krop; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Masabumi Shibuya; Peter Carmeliet; Raquel Soares; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

2.  Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy.

Authors:  Jenny Yao; Xiumin Wu; Guanglei Zhuang; Ian M Kasman; Tobias Vogt; Vernon Phan; Masabumi Shibuya; Napoleone Ferrara; Carlos Bais
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 3.  Role of placenta growth factor in cancer and inflammation.

Authors:  Ki Jo Kim; Chul Soo Cho; Wan Uk Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

4.  Natural cytotoxicity receptor 1 in mouse uNK cell maturation and function.

Authors:  A M Felker; B A Croy
Journal:  Mucosal Immunol       Date:  2017-01-18       Impact factor: 7.313

Review 5.  Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.

Authors:  Jochen G Schneider; Sarah R Amend; Katherine N Weilbaecher
Journal:  Bone       Date:  2010-09-17       Impact factor: 4.398

6.  B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry.

Authors:  Domenico Ribatti; Beatrice Nico; Anca Maria Cimpean; Marius Raica; Enrico Crivellato; Simona Ruggieri; Angelo Vacca
Journal:  Clin Exp Med       Date:  2012-04-19       Impact factor: 3.984

Review 7.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.

Authors:  Daniela Trisciuoglio; Teresa De Luca; Marianna Desideri; Daniela Passeri; Chiara Gabellini; Stefania Scarpino; Chengyu Liang; Augusto Orlandi; Donatella Del Bufalo
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

9.  Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.

Authors:  Debora Faraone; Maria Simona Aguzzi; Gabriele Toietta; Angelo M Facchiano; Francesco Facchiano; Alessandra Magenta; Fabio Martelli; Silvia Truffa; Eleonora Cesareo; Domenico Ribatti; Maurizio C Capogrossi; Antonio Facchiano
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

Review 10.  HIF-mediated endothelial response during cancer progression.

Authors:  Colin E Evans; Cristina Branco-Price; Randall S Johnson
Journal:  Int J Hematol       Date:  2012-05-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.